article thumbnail

B2B Sales Prospecting: What You Need To Know

Spotio

Business-to-business (B2B) prospecting is the pillar of lead generation. When prospecting for new business, the goal is to identify as many quality prospects as possible. However, B2B sales prospecting strategy is not as easy as it sounds. When it comes to prospecting, B2B companies face a quality and quantity problem.

article thumbnail

Prospecting Roundup: 7 Articles to Improve Your Sales Team’s Prospecting Effectiveness

The Brooks Group

As the year comes to a close and your team is busy trying to meet their Q4 target, don’t let prospecting for the new year fall by the wayside. Even the most skilled salespeople can’t close a deal if they aren’t capable of getting in front of the right people, so your team’s prospecting effectiveness should be your top priority for 2016.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Build a Top Performing Sales Team in 2016

The Brooks Group

The key to building an all-star team in 2016 is having the right people in the right positions, doing the work they were naturally wired for. As your team plans for growth in 2016, you’ll want to make sure you’re putting the right people in leadership positions. Promote the right people to leadership positions. Learn More.

Sales 40
article thumbnail

Get Your Sales Team Prospecting Smarter, Not Harder

The Brooks Group

But at the field level, for sales reps who are generally fast-paced and enjoy selling more than planning , getting disciplined around prospecting can be a challenge. Simply setting aside a time for prospecting won’t guarantee success, however. Focus on Prospect Quality, Not Size. Leverage the Power of LinkedIn.

article thumbnail

Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test

Legacy MEDSearch

of specificity in the case-control study, THUNDER, and will be further validated in prospective interventional studies among asymptomatic population. OverC MCDBT demonstrated a 69.1% of sensitivity and 98.9%

FDA 95
article thumbnail

FDA approval for Janssen’s prostate cancer treatment

European Pharmaceutical Review

“We prospectively designed the MAGNITUDE study to identify the subset of patients most likely to benefit from targeted treatment with AKEEGA and to help us understand how we can potentially achieve better health outcomes for patients.” ” In April 2016, Janssen Biotech, Inc.

FDA 52
article thumbnail

Expand your US Client Base

eatNgage

market client base simply and effectively: Get to know your prospects. Getting to know your prospects can mean the difference between closing the deal and missing out on a golden opportunity. It allows you to dine and interact with prospects face to face in a remote fashion. business associates. Save time and money.